In summary, these studies demonstrate that inhaled corticosteroid use suppresses antiviral immune responses, accompanied by adverse effects on mucin production and antibacterial immunity during virus-induced COPD exacerbations. Here, MUC5AC is linked to chronic obstructive pulmonary disease.